JACKIE FONUA: Open Payments
NPI 1336227206 · WEST JORDAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,260 in 61 payments from 14 companies in 2025. Trend: 2023 $1,087 · 2024 $1,206 · 2025 $1,260
Food & beverage: $1,260
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $369 |
| ABBVIE INC. | 17 | $237 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $162 |
| Indivior Inc. | 4 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $65 |
| PFIZER INC. | 4 | $64 |
| Inspire Medical Systems, Inc. | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Lilly USA, LLC | 2 | $30 |
Products named: FARXIGA, CAPLYTA, BREZTRI, VRAYLAR, QULIPTA, SUBLOCADE, JARDIANCE, Kerendia.
Industry payments across UT — which companies pay providers there.
